According to GuruFocus Insider Data, these are the largest CEO buys during the past week.Â
OPKO Health CEO bought 135,000 shares
OPKO Health Inc. (OPK, Financial) CEO, Chairman and 10% owner Phillip Frost bought 135,000 shares during the past week.
Frost bought 80,000 shares for $6.01 per share on Sept. 15; 40,000 shares for $6 per share on Sept. 18; and 15,000 shares for $6.01 per share on Sept. 19.
OPKO is a diversified health care company. Its business includes diagnostics and provision of pharmaceutical products. The company has a market cap of $3.75 billion. Its shares traded at $6.71 with a price-earnings (P/E) ratio of -45.34 as of Sept. 22.
Revenue for the three months ending June 30 was $314.2 million.
Senior Vice President and Chief Financial Officer (CFO) Adam Logal bought 1,500 shares for $6.03 per share on Sept. 15. The stock price has increased by 11.28% since.
Cleveland-Cliffs CEO bought 100,000 shares
Cleveland-Cliffs Inc. (CLF, Financial) Chairman, President and CEO Lourenco Goncalves bought 100,000 shares for $7.11 per share on Sept. 15. The stock price has decreased by 3.52% since.
Cleveland-Cliffs, formerly Cliffs Natural Resources, is an iron ore producer. It operates mining properties in North America, the U.S., Canada and Australia and also owns a large chromite project in Canada. The company has a market cap of $2.034 billion. Its shares traded at $6.86 with a P/E ratio of 31.47 as of Sept. 22.
Net income for the three months ended July 27 was $30.1 million as compared to $29.5 million for the prior-year period.
Lexicon Pharmaceuticals CEO bought 30,000 shares
Lexicon Pharmaceuticals Inc. (LXRX, Financial) President and CEO Lonnel Coats bought 30,000 shares for $12.54 per share on Sept. 15. The stock price has decreased by 1.2% since.
Lexicon operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease. The company has a market cap of $1.308 billion. Its shares traded at $12.39 with a price-earnings (P/E) ratio of -9.35 as of Sept. 22.
Revenues for the three months ended June 30 decreased to $12.1 million from $20.1 million for the corresponding period in 2016.
Director Sam L. Barker bought 1,000 shares for $12.5 per share on Sept. 15. The stock price has decreased by 0.88% since.
Delek Logistics Partners CEO bought 7,000 shares
Delek Logistics Partners LP (DKL, Financial) Chairman/CEO Ezra Uzi Yemin bought 7,000 shares for $29.70 per share on Sept. 15. The stock price has increased by 0.17% since.
Delek owns and operates logistics and marketing assets for crude oil and intermediate and refined products. It operates in two segments, Pipelines and Transportation, and Wholesale Marketing and Terminaling. The company has a market cap of $739.543 million. Its shares traded at $29.75 with a P/E ratio of 15.68 as of Sept. 22.
Net income for the second quarter was $19.0 million as compared to net income of $18.9 million for the second quarter of 2016.
Yemin bought 3,500 shares for $29 per share on Sept. 12. The stock price has increased by 2.59% since.
Radius Health CEO bought 6,100 shares
Radius Health Inc. (RDUS, Financial) President and CEO Jesper Hoiland bought 6,100 shares for $32.72 per share on Sept. 15. The stock price has increased by 7.49% since.
Radius Health is a science-driven biopharmaceutical company engaged in developing new therapeutics for patients with osteoporosis and other serious endocrine-mediated diseases. The company has a market cap of $1.53 billion. Its shares traded at $35.17 with a P/E ratio of -6.78 as of Sept. 22.
For the three months ended June 30, Radius reported a net loss of $68.4 million compared to a net loss of $43.4 millionvfor the three months ended June 30, 2016.
CFO Jose Carmona bought 3,000 shares for $32.83 per share on Sept. 14. The share price has increased by 7.13% since.
Biotech Growth NV, a 10% owner, bought 50,000 shares on Sept. 5 for $36.75; 50,000 shares for $35.42 per share on Sept. 12; and 150,000 shares on Sept. 14 for $33.45 per share.
For the complete list of stocks that bought by their company CEOs, go to: CEO Buys.
Disclosure: I do not own stock in any of the companies mentioned in the article.
